Moderna Provides Update on Timing of U.S. Emergency Use Authorization of its COVID-19 Vaccine for Adolescents
Go back to Moderna Provides Update on Timing of U.S. Emergency Use Authorization of its COVID-19 Vaccine for Adolescents| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 140.33 -5.22 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.55 | 52 Week High | $0.52 | |||
| Open | $145.98 | 52 Week Low | $0.08 | |||
| Day High | $147.50 | P/E | N/A | |||
| Day Low | $139.70 | EPS | $-3.80 | |||
| Volume | 10,276,802 | |||||
